Role of SIK1 in the transition of acute kidney injury into chronic kidney disease.

J Transl Med

Department of Nephrology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.

Published: February 2021

AI Article Synopsis

  • Acute kidney injury (AKI) is a significant risk factor for chronic kidney disease (CKD), and the transition from AKI to CKD is a critical concern in renal health, with recent studies highlighting the role of salt inducible kinase 1 (SIK1) in this process.
  • SIK1 expression is notably reduced in AKI patients and models, and experiments show that enhancing SIK1 can mitigate AKI-CKD transition and kidney cell damage, implicating SIK1's protective role.
  • The study reveals that SIK1 influences the AKI-CKD transition by regulating the WNT/β-catenin signaling pathway, a key player in the associated complications, offering potential new strategies for prevention and treatment

Article Abstract

Background: Acute kidney injury (AKI), with a high morbidity and mortality, is recognized as a risk factor for chronic kidney disease (CKD). AKI-CKD transition has been regarded as one of the most pressing unmet needs in renal diseases. Recently, studies have showed that salt inducible kinase 1 (SIK1) plays a role in epithelial-mesenchymal transition (EMT) and inflammation, which are the hallmarks of AKI-CKD transition. However, whether SIK1 is involved in AKI-CKD transition and by what mechanism it regulates AKI-CKD transition remains unknown.

Methods: We firstly detected the expression of SIK1 in kidney tissues of AKI patients and AKI mice by immunohistochemistry staining, and then we established Aristolochic acid (AA)-induced AKI-CKD transition model in C57BL/6 mice and HK2 cells. Subsequently, we performed immunohistochemistry staining, ELISA, real-time PCR, Western blot, immunofluorescence staining and Transwell assay to explore the role and underlying mechanism of SIK1 on AKI-CKD transition.

Results: The expression of SIK1 was down-regulated in AKI patients, AKI mice, AA-induced AKI-CKD transition mice, and HK2 cells. Functional analysis revealed that overexpression of SIK1 alleviated AA-induced AKI-CKD transition and HK2 cells injury in vivo and in vitro. Mechanistically, we demonstrated that SIK1 mediated AA-induced AKI-CKD transition by regulating WNT/β-catenin signaling, the canonical pathway involved in EMT, inflammation and renal fibrosis. In addition, we discovered that inhibition of WNT/β-catenin pathway and its downstream transcription factor Twist1 ameliorated HK2 cells injury, delaying the progression of AKI-CKD transition.

Conclusions: Our study demonstrated, for the first time, a protective role of SIK1 in AKI-CKD transition by regulating WNT/β-catenin signaling pathway and its downstream transcription factor Twist1, which will provide novel insights into the prevention and treatment AKI-CKD transition in the future.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885408PMC
http://dx.doi.org/10.1186/s12967-021-02717-5DOI Listing

Publication Analysis

Top Keywords

aki-ckd transition
40
aa-induced aki-ckd
16
hk2 cells
16
transition
12
aki-ckd
12
role sik1
8
acute kidney
8
kidney injury
8
chronic kidney
8
kidney disease
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!